News from celsion corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 07, 2016, 08:00 ET

Celsion Reports Translational Research Data from its Phase 1b Study of GEN-1 Immunotherapy in Recurrent Ovarian Cancer

 Celsion Corporation (NASDAQ: CLSN), today announced new translational data from its Phase 1b study of GEN-1 in patients with...

Dec 17, 2015, 08:00 ET

Celsion Announces Appointment of Two New Members to Its Board of Directors

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

Dec 16, 2015, 08:00 ET

Celsion Receives CFDA Approval to Conduct the OPTIMA Study in China

Celsion Corporation (NASDAQ: CLSN) today announced that it has received Clinical Trial Application (CTA) approval from the China Food and Drug...

Dec 14, 2015, 08:00 ET

Celsion Announces Presentation of DIGNITY Phase I/II ThermoDox® Data at the 2015 San Antonio Breast Cancer Symposium

Celsion Corporation (NASDAQ: CLSN) today announced the presentation of results from its ongoing Phase I/II US DIGNITY Study of ThermoDox® in...

Nov 24, 2015, 08:00 ET

Celsion Corporation to Present at the LD Micro Main Event Investor Conference

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

Nov 11, 2015, 18:00 ET

Celsion Corporation Announces Dual Listing on the Tel Aviv Stock Exchange

 Celsion Corporation (NASDAQ: CLSN), a fully integrated oncology company focused on the development of a portfolio of innovative cancer...

Nov 05, 2015, 08:00 ET

Celsion Corporation Reports Third Quarter 2015 Financial Results and Provides Business Update

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the quarter ended September...

Nov 03, 2015, 08:00 ET

Celsion Corporation Names Edwin De Wit, M.D. as Senior Vice President and Head of Medical, Europe

Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments,...

Nov 02, 2015, 08:00 ET

Celsion Presents Data on ThermoDox® plus Optimized RFA in Intermediate HCC at the 2nd Asian Conference on Tumor Ablation (ACTA)

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the presentation of data from the Company's HEAT...

Oct 29, 2015, 08:00 ET

Celsion Corporation to Hold Third Quarter 2015 Financial Results Conference Call on Thursday, November 5, 2015

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its third quarter 2015 financial...

Oct 15, 2015, 08:00 ET

Celsion to Host Research and Development Day on October 27, 2015

 Celsion Corporation (NASDAQ: CLSN) today announced that it will host a Research and Development (R&D) Day for investors and analysts on...

Oct 12, 2015, 08:00 ET

Celsion Announces Impressive Preclinical Data for its GEN-1 IL-12 Immunotherapy in Combination with Avastin® and Doxil® for Ovarian Cancer

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today reported data from a large preclinical study of the Company's GEN-1...

Oct 06, 2015, 08:00 ET

Celsion Announces Upcoming Presentations at the 2nd Asian Conference on Tumor Ablation on October 30-31, 2015

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the upcoming presentations of data supporting the...

Sep 30, 2015, 08:00 ET

Celsion Corporation Enrolls First Patient in the OVATION Study

 Celsion Corporation (Celsion) (NASDAQ:CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative...

Sep 09, 2015, 08:00 ET

Celsion Completes Integration of EGEN and Outlines Clinical Development Plan for GEN-1 IL-12 Immunotherapy Program

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

Sep 08, 2015, 08:00 ET

Celsion Announces Highlights from Symposium at the International Liver Cancer Association 2015 Annual Conference

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced highlights from presentations by three leading...

Sep 03, 2015, 08:00 ET

Celsion to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's Chairman,...

Aug 10, 2015, 08:30 ET

Celsion and myTomorrows Expand ThermoDox® European Early Access Program to Include Patients with Primary Liver Cancer and Liver Cancer Metastases

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that it has expanded its Early Access Program (EAP) for...

Aug 10, 2015, 08:00 ET

Celsion Corporation Reports Second Quarter 2015 Financial Results and Provides Business Update

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the quarter ended June 30,...

Aug 07, 2015, 06:22 ET

Celsion Corporation anuncia los datos de supervivencia general actualizados del estudio HEAT de ThermoDox®

- Celsion Corporation anuncia los datos de supervivencia general actualizados del estudio HEAT de ThermoDox® en cáncer hepático...